Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Targeted Medical Pharma Inc Announces Initial Results from a Clinical Observation of Medical Foods for Autistic Spectrum Disorder Symptoms


Tuesday, 12 Nov 2013 06:49pm EST 

Targeted Medical Pharma Inc announced preliminary findings from an investigator initiated clinical observation of amino acid based medical foods to address specific nutrient deficiencies in children with autism spectrum disease (ASD) symptoms. 26 children ages seven to sixteen were treated for a time period ranging between 30 days and 1 year, who were diagnosed with ASD or suffering from related symptoms including explosive behavior, social isolation, and mood disorder. The investigator reported that children demonstrated significant improvement with regards to decreased disruptive outbursts, improved socialization, improved mood and reduction in drug dose. 100% of patients have responded positively with an average improvement in explosive outbursts at 83% compared to baseline, with patients also demonstrating significant improvements in anxiety and mood regulation. 

Company Quote

0.81
0.08 +10.96%
18 Jul 2014